NCT00553696 - Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

March 31, 2014

Conditions

Stomach Neoplasms

Interventions

DRUG

Cisplatin

Cisplatin 60 mg/m2 on day 1 of each 28 day cycle

DRUG

S-1

S-1 80 mg/m2 on days 1-21 of each 28 day cycle

DRUG

Sunitinib

Sunitinib 25 mg, 37.5 mg and 50 mg daily S-1 80 mg/m2 on days 1-21 of each 28 day cycle Cisplatin 60 mg/m2 on day 1 of each 28 day cycle

Trial Locations (3)

Aichi cancer center central hospital / Medical Oncology, Nagoya

Saku Central Hospital, GI Devision, Saku

Shizuoka Cancer Center, Suntougun